WO2011065123A1 - Cosmetic - Google Patents

Cosmetic Download PDF

Info

Publication number
WO2011065123A1
WO2011065123A1 PCT/JP2010/067061 JP2010067061W WO2011065123A1 WO 2011065123 A1 WO2011065123 A1 WO 2011065123A1 JP 2010067061 W JP2010067061 W JP 2010067061W WO 2011065123 A1 WO2011065123 A1 WO 2011065123A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
component
poe
oil
formula
Prior art date
Application number
PCT/JP2010/067061
Other languages
French (fr)
Japanese (ja)
Inventor
祐子 鈴木
隆司 大森
Original Assignee
株式会社資生堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社資生堂 filed Critical 株式会社資生堂
Publication of WO2011065123A1 publication Critical patent/WO2011065123A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/893Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26Optical properties
    • A61K2800/262Transparent; Translucent

Definitions

  • the present invention relates to cosmetics. More specifically, the present invention relates to a transparent or translucent cosmetic that is excellent in preparation stability and speed of familiarity with the skin.
  • Skin cosmetics such as lotion are used for the purpose of imparting appropriate moisture to the skin and keeping the skin healthy.
  • Moisturizers are widely used as moisturizing ingredients, but cosmetics that contain a relatively large amount of water in addition to the moisturizer have a low affinity for the skin when applied and tend to be repelled on the skin. There was a problem that the feeling of penetration was bad.
  • dextran or a dextran derivative is blended (Patent Document 1), a water-in-oil cosmetic dosage form is selected (Patent Document 2), and raffinose.
  • Patent Document 3 A method of combining a certain amount and agar (Patent Document 3) has been adopted.
  • these conventional methods have problems such as safety concerns (skin on skin, etc.), alcohol odor, insufficient effect, and limited dosage form options.
  • the present invention has been made in view of the above-described conventional circumstances, and an object of the present invention is to provide a transparent or translucent cosmetic material that is excellent in the speed of familiarity with the skin and the stability of the preparation.
  • the present invention provides (a) a silicone surfactant represented by the following formula (I), (b) a polyoxypropylene of a higher saturated branched chain alcohol represented by the following formula (II), A transparent or translucent cosmetic containing a nonionic surfactant comprising a polyoxyethylene adduct is provided.
  • R 1 represents an alkyl group having 1 to 6 carbon atoms
  • R 2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms
  • k represents an average number of moles of added ethylene oxide groups; Numbers from 3 to 30 are shown.
  • R 3 represents an aliphatic saturated branched alkyl group having 20 to 30 carbon atoms; m represents an average added mole number of propylene oxide group of 11 to 15 (provided that higher saturation) And a polyoxypropylene adduct having a molecular weight of 930 or more in combination with the branched alcohol mother nucleus.); N represents an average number of moles of ethylene oxide groups added and 15 to 30.
  • the present invention also provides the cosmetic described above, wherein the amount of component (a) is 0.01 to 3.0% by mass.
  • the present invention also provides the cosmetic described above, wherein the amount of component (b) is 0.02 to 5.0% by mass.
  • a transparent or translucent cosmetic material that is excellent in the speed of familiarity with the skin and the stability of the preparation is provided.
  • a silicone surfactant represented by the following formula (I) is used as the component (a).
  • R 1 represents an alkyl group having 1 to 6 carbon atoms. A methyl group is preferred.
  • R 2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.
  • An alkyl group having 1 to 6 carbon atoms is preferable, and a methyl group is particularly preferable.
  • K is the average number of moles of ethylene oxide groups added and represents a number of 3 to 30, preferably 6 to 20.
  • k is the average number of moles of ethylene oxide groups added and represents a number of 3 to 30, preferably 6 to 20.
  • k is less than 3, the formulation stability is insufficient.
  • k exceeds 30, the familiarity with the skin is deteriorated.
  • the component (a) can be produced by a conventional method using a known technique. For example, alkyltrisiloxane, one-end alkyl-capped polyoxyalkylene, and the like are reacted (hydrosilylation reaction) in an organic solvent such as isopropyl alcohol. The reaction is carried out under a nitrogen atmosphere under reflux conditions, and chloroplatinic acid or the like is used as the catalyst. The target compound can be obtained by removing the solvent from the reaction solution with a separatory funnel or the like.
  • the component (a) mainly contributes to the speed of familiarity with the skin, and the blending amount thereof is preferably 0.01 to 3.0% by mass, more preferably 0.02 to 2%, based on the total amount of the cosmetic of the present invention. 0.0% by mass. If it is less than 0.01% by mass, it may be difficult to obtain enough to quickly satisfy the skin. It may be difficult to obtain the desired effect and the stability may be affected.
  • the component (b) is a nonionic surfactant comprising a polyoxypropylene or polyoxyethylene adduct of a higher saturated branched chain alcohol represented by the following formula (II).
  • R 3 represents an aliphatic saturated branched alkyl group having 20 to 30 carbon atoms. If the number of carbon atoms is less than 20 or exceeds 30, sufficient formulation stability cannot be obtained.
  • Specific examples of R 3 include, for example, 2-octyldodecyl group, 2-octyltetradecyl group, 2-octylhexadecyl group, 2-octyloctyldecyl group, 2-decyldodecyl group, 2-decyltetradecyl group, Examples include 2-decylhexadecyl group, 2-dodecyltetradecyl group, 2-dodecylhexadecyl group and the like.
  • m represents an average addition mole number of propylene oxide groups of 11 to 15 (provided that a polyoxypropylene adduct having a molecular weight of 930 or more combined with a higher saturated branched alcohol mother nucleus), preferably 12 to 14 It is. If m is less than 11 or more than 15, satisfactory results in formulation stability cannot be obtained.
  • N is the average number of moles of ethylene oxide groups added and represents a number of 15 to 30, preferably 18 to 26. When n is less than 15 or more than 30, satisfactory results in formulation stability cannot be obtained.
  • the component (b) mainly contributes to a translucent to transparent appearance, stability, etc., and its blending amount is preferably 0.02 to 5.0% by mass, more preferably 0.00%, based on the total amount of the cosmetic of the present invention. 05 to 4.0% by mass. If the amount is less than 0.02% by mass, the effect may not be sufficiently obtained. On the other hand, if the amount exceeds 5.0% by mass, the familiarity with the skin tends to deteriorate.
  • the blending ratio of the component (a) to the component (b) is less than 1/400, it is difficult to obtain a sufficiently satisfactory result in the speed of familiarity with the skin, whereas when it exceeds 90, the formulation stability tends to be poor. Be looked at.
  • “transparent to translucent” refers to those having a transparency in the range of 20 to 100 when the transparency of the purified water is 100 and the case where no light is transmitted is 0.
  • the milky milky emulsion has a transparency of 15 or less.
  • the transparency can be measured by a conventional method, for example, using a digital colorimetric color difference calculator (manufactured by Suga Test Instruments Co., Ltd.).
  • a moisturizer and surfactant usually incorporated as a base in cosmetics, in addition to the above components, within the range not impairing the effects of the present invention
  • Amphoteric surfactants, hydrophilic nonionic surfactants, etc. oils (hydrocarbon oils, synthetic ester oils, silicone oils, liquid fats, solid fats, waxes, etc.), higher fatty acids, higher alcohols, powder components, water-soluble Polymers (natural, semi-synthetic, synthetic), thickeners, UV absorbers, sequestering agents, lower alcohols, saccharides (monosaccharides, oligosaccharides, polysaccharides), organic amines, pH adjusters, vitamins, oxidation An inhibitor, an antioxidant assistant, other components that can be blended, and the like can be blended as necessary.
  • humectant examples include polyglycerin such as glycerin, diglycerin, triglycerin, tetraglycerin, ethylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, propylene glycol, dipropylene glycol, polyethylene glycol, 1, Examples include 3-propanediol, glucose, maltose, maltitol, sucrose, fructose, xylitol, sorbitol, maltotriose, threitol, erythritol, amylolytic sugar-reducing alcohol, polyglycerin derivative, polyoxyalkylene alkyl glucoside and the like.
  • polyglycerin such as glycerin, diglycerin, triglycerin, tetraglycerin, ethylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, propylene glycol, dipropylene glycol, polyethylene
  • glycerin diglycerin, 1,3-butylene glycol, 1,4-butylene glycol, dipropylene glycol, polyethylene glycol, xylitol, erythritol, and sorbitol are particularly preferable.
  • the blending amount varies slightly depending on the type of humectant, but is preferably 0.01 to 35.0% by mass.
  • Anionic surfactants include, for example, fatty acid soaps (eg, sodium laurate, sodium palmitate, etc.); higher alkyl sulfates (eg, sodium lauryl sulfate, potassium lauryl sulfate, etc.); alkyl ether sulfates (eg, POE lauryl sulfate triethanolamine, POE sodium lauryl sulfate, etc.); N-acyl sarcosine acid (eg, lauroyl sarcosine sodium, etc.); higher fatty acid amide sulfonates (eg, N-myristoyl-N-methyl taurine sodium, coconut oil fatty acid) Methyl tauride sodium, lauryl methyl tauride sodium, etc.); Phosphate ester salts (POE oleyl ether sodium phosphate, POE stearyl ether phosphate, etc.); Sulfosuccinate (eg, -2-sodium
  • Examples of the cationic surfactant include alkyltrimethylammonium salts (eg, stearyltrimethylammonium chloride, lauryltrimethylammonium chloride, etc.); alkylpyridinium salts (eg, cetylpyridinium chloride, etc.); distearyldimethylammonium dialkyldimethylammonium chloride; Poly (N, N'-dimethyl-3,5-methylenepiperidinium chloride); alkyl quaternary ammonium salt; alkyldimethylbenzylammonium salt; alkylisoquinolinium salt; dialkyl morpholinium salt; POE alkylamine; Examples include amine salts; polyamine fatty acid derivatives; amyl alcohol fatty acid derivatives; benzalkonium chloride; benzethonium chloride and the like.
  • alkyltrimethylammonium salts eg, stearyltrimethylammonium chloride, lauryltrimethylammonium
  • amphoteric surfactants examples include imidazoline-based amphoteric surfactants (eg, 2-undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide). Side-1-carboxyethyloxy disodium salt, etc.); betaine surfactants (for example, 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetic acid betaine, alkylbetaine, amide betaine) , Sulfobetaine, etc.).
  • imidazoline-based amphoteric surfactants eg, 2-undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide).
  • hydrophilic nonionic surfactants include POE sorbitan fatty acid esters (eg, POE sorbitan monooleate, POE sorbitan monostearate, POE sorbitan tetraoleate); POE sorbite fatty acid esters (eg, POE sorbit) Monolaurate, POE sorbite monooleate, POE sorbite pentaoleate, POE sorbite monostearate, etc.); POE glycerin fatty acid esters (for example, POE glycerin monostearate, POE glycerin monoisostearate, POE glycerin triisostearate) POE monooleate such as a rate); POE fatty acid esters (eg, POE distearate, POE monodiolate, ethylene glycol distearate, etc.); P E alkyl ethers (for example, POE lauryl ether, POE o
  • hydrocarbon oil examples include liquid paraffin, isododecane, isohexadecane, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, and the like.
  • Synthetic ester oils include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate, myristyl lactate , Isocetyl stearate, isocetyl isostearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, di-2-heptyl Glycerin undecanoate, tri-2-ethylhexanoic acid trimethylolpropane, triisostearic acid tri
  • silicone oil examples include linear polysiloxanes (for example, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxanes (for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexyl).
  • silicone resins that form a three-dimensional network structure various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.) It is done.
  • liquid fats examples include avocado oil, camellia oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, eno oil , Soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, snail oil, Japanese drill oil, jojoba oil, germ oil and the like.
  • solid fat examples include cocoa butter, coconut oil, hardened coconut oil, palm oil, palm kernel oil, owl kernel oil, hardened oil, owl, and hardened castor oil.
  • waxes examples include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, montan wax, nukarou, kapok wax, sugar cane wax, jojoballow, shellac wax, and the like.
  • higher fatty acids examples include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, toluic acid, isostearic acid, linoleic acid, linolenic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid ( DHA) and the like.
  • higher alcohols examples include linear alcohols (eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol); branched chain alcohols (eg, monostearyl glycerin ether (batyl alcohol) ), 2-decyltetradecinol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol and the like.
  • linear alcohols eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol
  • branched chain alcohols eg, monostearyl glycerin ether (batyl alcohol)
  • 2-decyltetradecinol eg., phytosterol, hexyldodecanol, isostearyl alcohol, o
  • the powder component examples include inorganic powders (for example, talc, kaolin, mica, sericite (sericite), muscovite, phlogopite, synthetic mica, saucite, biotite, permiculite, magnesium carbonate, calcium carbonate, silicic acid.
  • inorganic powders for example, talc, kaolin, mica, sericite (sericite), muscovite, phlogopite, synthetic mica, saucite, biotite, permiculite, magnesium carbonate, calcium carbonate, silicic acid.
  • Red No. 104 Red No. 106, Red No. 227, Red No. 230, Red No. 401, Red No. 505, Orange No. 205, Yellow No. 4, Yellow No. 5, Yellow No. 202, Yellow No. 203, Green No. 3 and Blue No. 1
  • natural pigments for example, chlorophyll, ⁇ -carotene, etc.
  • water-soluble polymers examples include gum arabic, gum tragacanth, galactan, guar gum, locust bean gum, tamarind gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), alge colloid (gypsum extract), starch (rice, corn, Potato, wheat), plant water-soluble polymers such as glycyrrhizic acid; microbial water-soluble polymers such as xanthan gum, dextran, succinoglycan, and bullulan; animal water-soluble polymers such as collagen, casein, albumin, and gelatin; Starch-based water-soluble polymers such as carboxymethyl starch and methylhydroxypropyl starch; methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethyl Cellulose water-soluble polymers such as cellulose cellulose, sodium cellulose sulfate, hydroxypropyl cellulose, carboxymethyl cellulose
  • ultraviolet absorber examples include benzoic acid-based ultraviolet absorbers (for example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester.
  • PABA paraaminobenzoic acid
  • PABA monoglycerin ester N, N-dipropoxy PABA ethyl ester
  • N, N-diethoxy PABA ethyl ester examples include benzoic acid-based ultraviolet absorbers (for example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester.
  • PABA paraaminobenzoic acid
  • sequestering agent examples include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, disodium edetate, trisodium edetate, and tetrasodium edetate. , Sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, edetic acid, trisodium ethylenediaminehydroxyethyl triacetate and the like.
  • lower alcohols examples include ethanol, propanol, isopropanol, isobutyl alcohol, t-butyl alcohol and the like.
  • Monosaccharides include, for example, tricarbon sugars (eg, D-glyceryl aldehyde, dihydroxyacetone, etc.); tetracarbon sugars (eg, D-erythrose, D-erythrulose, D-treose, erythritol, etc.); pentose sugars (eg, L-arabinose, D-xylose, L-lyxose, D-arabinose, D-ribose, D-ribulose, D-xylulose, L-xylulose, etc .; hexose (eg, D-glucose, D-talose, D) -Bucicose, D-galactose, D-fructose, L-galactose, L-mannose, D-tagatose, etc.); pentose sugar (eg, aldheptose, heproose, etc.); octo
  • oligosaccharides examples include guanthianose, umbelliferose, lactose, planteose, isoliquinoses, ⁇ , ⁇ -trehalose, raffinose, lycnose, umbilicin, stachyose verbus courses and the like.
  • polysaccharide examples include chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, keratan sulfate, chondroitin, mucoitin sulfate, keratosulfuric acid, succinoglucan, and caronic acid.
  • amino acids examples include neutral amino acids (eg, threonine, cysteine, etc.); basic amino acids (eg, hydroxylysine, etc.), and the like.
  • amino acid derivatives include acyl sarcosine sodium (lauroyl sarcosine sodium), acyl glutamate, acyl ⁇ -alanine sodium, glutathione, pyrrolidone carboxylic acid and the like.
  • organic amines examples include monoethanolamine, diethanolamine, triethanolamine, morpholine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, and 2-amino-2-methyl-1-propanol. Is mentioned.
  • pH adjuster examples include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
  • vitamins examples include vitamins A, B1, B2, B6, C, E and derivatives thereof, pantothenic acid and derivatives thereof, biotin and the like.
  • antioxidants examples include tocopherols, dibutylhydroxytoluene, butylhydroxyanisole, gallic acid esters and the like.
  • antioxidant assistant examples include phosphoric acid, citric acid, ascorbic acid, maleic acid, malonic acid, succinic acid, fumaric acid, kephalin, hexametaphosphate, phytic acid, ethylenediaminetetraacetic acid and the like.
  • ingredients that can be blended include, for example, preservatives (phenoxyethanol, ethylparaben, etc.); anti-inflammatory agents (eg, glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin, etc.); whitening agents (for example, (Yukinoshita extract, arbutin, etc.); various extracts (for example, buckwheat, auren, shikon, peonies, assembly, birch, sage, loquat, carrot, aloe, mallow, iris, grape, yokuinin, loofah, lily, saffron, nematode, Ginger, hypericum, onion, garlic, red pepper, chimney, red pepper, seaweed, etc., activator (eg, royal jelly, photosensitizer, etc.); blood circulation promoter (eg, nonyl acid wallenyl
  • the dosage form of the cosmetic of the present invention is not particularly limited as long as it can be applied to the skin, and examples thereof include skin lotion, lotion, and an impregnating liquid impregnated into a sheet-like base.
  • Example 1 Samples 1 to 20 shown in Tables 1 and 2 below were prepared. Each sample was prepared by mixing the components corresponding to (1) to (11) and separately adding this to the mixture of (12) and (13).
  • Samples 7 to 20 that satisfy the constituent requirements of the present invention have excellent effects in all of translucency to transparency, formulation stability, and speed of familiarity with the skin. It was. On the other hand, Samples 1 to 6 that do not satisfy the constituent requirements of the present invention could not have all the effects of the present invention. For example, sample 1 did not contain both component (a) and component (b), and the formulation stability and the speed of familiarity with the skin were not sufficient. Sample 2 contained the component (b) but did not contain the component (a), and the speed of familiarity with the skin was not sufficient. In Sample 3, the component (a) was included but the component (b) was not included, a transparent or translucent appearance was not obtained, and the formulation stability was poor.
  • sample 4 when other nonionic surfactant was used instead of the component (b), a transparent or translucent appearance was not obtained, and the preparation stability was not sufficient.
  • samples 5 and 6 when other silicone surfactant was used instead of component (a), the speed of familiarity with the skin was not obtained.
  • a transparent or translucent cosmetic material that is excellent in the speed of familiarity with the skin and the stability of the preparation is provided.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Disclosed is a transparent or translucent cosmetic which can fit to the skin rapidly and has excellent preparation stability. Specifically disclosed is a transparent or translucent cosmetic containing (a) a silicone surfactant represented by formula (I) and (b) a nonionic surfactant comprising a polyoxypropylene-polyoxyethylene adduct of a higher saturated branched alcohol, wherein the adduct is represented by formula (II). [In formula (I), R1 represents a C1-6 alkyl group; R2 represents H or a C1-6 alkyl group; and k represents a numeral value of 3 to 30.] [In formula (II), R3 represents a C20-30 aliphatic saturated branched alkyl group; m represents a numeral value of 11 to 15 (so as to represent a POP adduct that has a molecular weight of 930 or more when combined with a higher saturated branched alcohol mother nucleus); and n represents a numeral value of 15 to 30.]

Description

化粧料Cosmetics
 本発明は化粧料に関する。さらに詳しくは、製剤安定性、肌へのなじみの早さに優れる透明乃至半透明な化粧料に関する。 The present invention relates to cosmetics. More specifically, the present invention relates to a transparent or translucent cosmetic that is excellent in preparation stability and speed of familiarity with the skin.
 化粧水をはじめとする皮膚化粧料は、皮膚に適度な潤いを与え、皮膚を健康に保つ目的で使用される。潤いを与える成分として保湿剤が広く用いられているが、保湿剤に加えて比較的水を多く含有する化粧料では、塗布時の皮膚への親和性が低く、肌の上ではじかれる傾向にあり、浸透感が悪く感じられる問題があった。このような問題に対し従来は、エタノールを添加するといった方法のほか、デキストラン若しくはデキストラン誘導体を配合する(特許文献1)、油中水型化粧料の剤型を選択する(特許文献2)、ラフィノースと寒天を組み合わせて一定量配合する(特許文献3)、等の方法が採られてきた。しかしこれら従来の方法では、安全性への懸念(肌にしみる等)やアルコール臭、効果が十分でない、剤型の選択肢が限られる、といった課題があった。 Skin cosmetics such as lotion are used for the purpose of imparting appropriate moisture to the skin and keeping the skin healthy. Moisturizers are widely used as moisturizing ingredients, but cosmetics that contain a relatively large amount of water in addition to the moisturizer have a low affinity for the skin when applied and tend to be repelled on the skin. There was a problem that the feeling of penetration was bad. Conventionally, in addition to the method of adding ethanol, dextran or a dextran derivative is blended (Patent Document 1), a water-in-oil cosmetic dosage form is selected (Patent Document 2), and raffinose. A method of combining a certain amount and agar (Patent Document 3) has been adopted. However, these conventional methods have problems such as safety concerns (skin on skin, etc.), alcohol odor, insufficient effect, and limited dosage form options.
 ところで、特に水系皮膚化粧料においては、外観が半透明~透明を呈するものが好まれる傾向がある。半透明~透明な化粧料とするために乳化剤や可溶化剤(例えば、非イオン界面活性剤等)などを用いる方法などが挙げられるが、現状では浸透感の点において十分な効果を得るのが難しい。 By the way, especially in the case of water-based skin cosmetics, those having a translucent to transparent appearance tend to be preferred. For example, a method using an emulsifier or a solubilizing agent (for example, a nonionic surfactant) is used to make a translucent to transparent cosmetic. However, at present, sufficient effects can be obtained in terms of penetrating feeling. difficult.
 したがって、半透明~透明な外観とともに、使用性(肌へのなじみの早さ)を満足し、かつ、製剤安定性にも優れる化粧料が求められている。 Therefore, there is a demand for cosmetics that have a translucent to transparent appearance, satisfy usability (fastness to skin), and have excellent formulation stability.
特開2004-059473号公報JP 2004-059473 A 特開2004-161698号公報JP 2004-161698 A 特開2007-269747号公報JP 2007-269747 A
 本発明は上記従来の事情に鑑みてなされたもので、肌へのなじみの早さ、製剤安定性に優れる透明乃至半透明な化粧料を提供することを目的とする。 The present invention has been made in view of the above-described conventional circumstances, and an object of the present invention is to provide a transparent or translucent cosmetic material that is excellent in the speed of familiarity with the skin and the stability of the preparation.
 上記課題を解決するために本発明は、(a)下記式(I)で示されるシリコーン系界面活性剤と、(b)下記式(II)で示される高級飽和分岐鎖アルコールのポリオキシプロピレン、ポリオキシエチレン付加物からなる非イオン界面活性剤を含有する、透明乃至半透明な化粧料を提供する。 In order to solve the above problems, the present invention provides (a) a silicone surfactant represented by the following formula (I), (b) a polyoxypropylene of a higher saturated branched chain alcohol represented by the following formula (II), A transparent or translucent cosmetic containing a nonionic surfactant comprising a polyoxyethylene adduct is provided.
Figure JPOXMLDOC01-appb-I000003
Figure JPOXMLDOC01-appb-I000003
〔式(I)中、R1は炭素原子数1~6のアルキル基を示し;R2は水素原子または炭素原子数1~6のアルキル基を示し;kはエチレンオキシド基の平均付加モル数で3~30の数を示す。〕 [In the formula (I), R 1 represents an alkyl group having 1 to 6 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; k represents an average number of moles of added ethylene oxide groups; Numbers from 3 to 30 are shown. ]
Figure JPOXMLDOC01-appb-I000004
Figure JPOXMLDOC01-appb-I000004
〔式(II)中、R3は炭素原子数20~30の脂肪族飽和分岐鎖アルキル基を示し;mはプロピレンオキシド基の平均付加モル数で11~15の数を示し(但し、高級飽和分岐アルコール母核と合せた分子量が930以上のポリオキシプロピレン付加物を示す。);nはエチレンオキシド基の平均付加モル数で15~30の数を示す。〕
 また本発明は、(a)成分の配合量が0.01~3.0質量%である、上記化粧料を提供する。
[In the formula (II), R 3 represents an aliphatic saturated branched alkyl group having 20 to 30 carbon atoms; m represents an average added mole number of propylene oxide group of 11 to 15 (provided that higher saturation) And a polyoxypropylene adduct having a molecular weight of 930 or more in combination with the branched alcohol mother nucleus.); N represents an average number of moles of ethylene oxide groups added and 15 to 30. ]
The present invention also provides the cosmetic described above, wherein the amount of component (a) is 0.01 to 3.0% by mass.
 また本発明は、(b)成分の配合量が0.02~5.0質量%である、上記化粧料を提供する。 The present invention also provides the cosmetic described above, wherein the amount of component (b) is 0.02 to 5.0% by mass.
 また本発明は、(a)成分と(b)成分の配合比が(a)成分/(b)成分=1/400~90/1(質量比)である、上記化粧料を提供する。 The present invention also provides the cosmetic described above, wherein the blending ratio of the component (a) and the component (b) is (a) component / (b) component = 1/400 to 90/1 (mass ratio).
 本発明により、肌へのなじみの早さ、製剤安定性に優れる透明乃至半透明な化粧料が提供される。 According to the present invention, a transparent or translucent cosmetic material that is excellent in the speed of familiarity with the skin and the stability of the preparation is provided.
 以下、本発明について詳述する。 Hereinafter, the present invention will be described in detail.
 本発明では(a)成分として下記式(I)で示されるシリコーン系界面活性剤を用いる。 In the present invention, a silicone surfactant represented by the following formula (I) is used as the component (a).
Figure JPOXMLDOC01-appb-I000005
Figure JPOXMLDOC01-appb-I000005
 式(I)中、R1は炭素原子数1~6のアルキル基を示す。好ましくはメチル基である。 In the formula (I), R 1 represents an alkyl group having 1 to 6 carbon atoms. A methyl group is preferred.
 R2は水素原子または炭素原子数1~6のアルキル基を示す。好ましくは炭素原子数1~6のアルキル基であり、中でもメチル基が好ましい。 R 2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. An alkyl group having 1 to 6 carbon atoms is preferable, and a methyl group is particularly preferable.
 kはエチレンオキシド基の平均付加モル数で、3~30の数を示し、好ましくは6~20の数を示す。kが3未満では製剤安定性が不十分となり、一方、30を超えると肌へのなじみが悪くなる。 K is the average number of moles of ethylene oxide groups added and represents a number of 3 to 30, preferably 6 to 20. When k is less than 3, the formulation stability is insufficient. On the other hand, when k exceeds 30, the familiarity with the skin is deteriorated.
 (a)成分は公知の技術を用いて常法により製造することができる。例えば、イソプロピルアルコールなどの有機溶媒中で、アルキルトリシロキサン、片末端アルキル封鎖ポリオキシアルキレンなどを反応(ヒドロシリル化反応)させる。反応は窒素雰囲気下、還流条件下で行い、触媒は塩化白金酸などを用いる。この反応液から分液漏斗などで溶媒を除くことにより目的化合物を得ることができる。 The component (a) can be produced by a conventional method using a known technique. For example, alkyltrisiloxane, one-end alkyl-capped polyoxyalkylene, and the like are reacted (hydrosilylation reaction) in an organic solvent such as isopropyl alcohol. The reaction is carried out under a nitrogen atmosphere under reflux conditions, and chloroplatinic acid or the like is used as the catalyst. The target compound can be obtained by removing the solvent from the reaction solution with a separatory funnel or the like.
 (a)成分はおもに肌へのなじみの早さに寄与し、その配合量は、本発明の化粧料全量中に0.01~3.0質量%が好ましく、より好ましくは0.02~2.0質量%である。0.01質量%未満では、肌へのなじみの早さを十分満足し得る程度にまで得ることが難しい場合があり、一方、3.0質量%を超えて配合しても配合量増大に見合った効果が得られ難く、安定性に影響が出ることも考えられる。 The component (a) mainly contributes to the speed of familiarity with the skin, and the blending amount thereof is preferably 0.01 to 3.0% by mass, more preferably 0.02 to 2%, based on the total amount of the cosmetic of the present invention. 0.0% by mass. If it is less than 0.01% by mass, it may be difficult to obtain enough to quickly satisfy the skin. It may be difficult to obtain the desired effect and the stability may be affected.
 (b)成分は下記式(II)で示される高級飽和分岐鎖アルコールのポリオキシプロピレン、ポリオキシエチレン付加物からなる非イオン界面活性剤である。 The component (b) is a nonionic surfactant comprising a polyoxypropylene or polyoxyethylene adduct of a higher saturated branched chain alcohol represented by the following formula (II).
Figure JPOXMLDOC01-appb-I000006
Figure JPOXMLDOC01-appb-I000006
 式(II)中、R3は炭素原子数20~30の脂肪族飽和分岐アルキル基を示す。炭素原子数が20未満、あるいは30を超えると十分な製剤安定性が得られない。R3の具体例としては、例えば、2-オクチルドデシル基、2-オクチルテトラデシル基、2-オクチルヘキサデシル基、2-オクチルオクチルデシル基、2-デシルドデシル基、2-デシルテトラデシル基、2-デシルヘキサデシル基、2-ドデシルテトラデシル基、2-ドデシルヘキサデシル基等が挙げられる。 In the formula (II), R 3 represents an aliphatic saturated branched alkyl group having 20 to 30 carbon atoms. If the number of carbon atoms is less than 20 or exceeds 30, sufficient formulation stability cannot be obtained. Specific examples of R 3 include, for example, 2-octyldodecyl group, 2-octyltetradecyl group, 2-octylhexadecyl group, 2-octyloctyldecyl group, 2-decyldodecyl group, 2-decyltetradecyl group, Examples include 2-decylhexadecyl group, 2-dodecyltetradecyl group, 2-dodecylhexadecyl group and the like.
 mはプロピレンオキシド基の平均付加モル数で11~15の数を示し(但し、高級飽和分岐アルコール母核と合せた分子量が930以上のポリオキシプロピレン付加物を示す。)、好ましくは12~14である。mが11未満、あるいは15を超えると、製剤安定性において満足のいく結果が得られなくなる。 m represents an average addition mole number of propylene oxide groups of 11 to 15 (provided that a polyoxypropylene adduct having a molecular weight of 930 or more combined with a higher saturated branched alcohol mother nucleus), preferably 12 to 14 It is. If m is less than 11 or more than 15, satisfactory results in formulation stability cannot be obtained.
 nはエチレンオキシド基の平均付加モル数で、15~30の数を示し、好ましくは18~26である。nが15未満、あるいは30を超えると、製剤安定性において満足のいく結果が得られなくなる。 N is the average number of moles of ethylene oxide groups added and represents a number of 15 to 30, preferably 18 to 26. When n is less than 15 or more than 30, satisfactory results in formulation stability cannot be obtained.
 (b)成分はおもに半透明~透明な外観や安定性等に寄与し、その配合量は、本発明の化粧料全量中に0.02~5.0質量%が好ましく、より好ましくは0.05~4.0質量%である。0.02質量%未満では、効果が十分出ない場合があり、一方、5.0質量%を超えると肌へのなじみが悪くなる傾向がみられる。 The component (b) mainly contributes to a translucent to transparent appearance, stability, etc., and its blending amount is preferably 0.02 to 5.0% by mass, more preferably 0.00%, based on the total amount of the cosmetic of the present invention. 05 to 4.0% by mass. If the amount is less than 0.02% by mass, the effect may not be sufficiently obtained. On the other hand, if the amount exceeds 5.0% by mass, the familiarity with the skin tends to deteriorate.
 本発明では上記(a)成分、(b)成分を、(a)成分/(b)成分=1/400~90/1(質量比)の範囲で配合するのが好ましく、より好ましくは1/300~80/1(質量比)である。(b)成分に対する(a)成分の配合比が1/400未満では肌へのなじみの早さにおいて十分満足のいく結果が得られ難く、一方、90を超えると製剤安定性が悪くなる傾向がみられる。 In the present invention, the components (a) and (b) are preferably blended in the range of (a) component / (b) component = 1/400 to 90/1 (mass ratio), more preferably 1 / 300 to 80/1 (mass ratio). When the blending ratio of the component (a) to the component (b) is less than 1/400, it is difficult to obtain a sufficiently satisfactory result in the speed of familiarity with the skin, whereas when it exceeds 90, the formulation stability tends to be poor. Be looked at.
 従来技術の欄で記載したように、従来、水を比較的多く含む化粧料では、塗布時の皮膚への親和性が低く、肌の上ではじかれる傾向にあり、浸透感が悪く感じられる問題があった。本発明では(a)成分、(b)成分を組み合せることによって初めて、上記のような水系の化粧料であっても肌へのなじみの早さに優れるとともに、製剤安定性にも優れ、透明乃至半透明な外観も得ることができるという優れた効果を奏することができる。 As described in the section of the prior art, conventionally, cosmetics containing a relatively large amount of water have a low affinity for the skin when applied, tend to be repelled on the skin, and the permeation feeling is felt poor was there. In the present invention, only by combining the components (a) and (b), the water-based cosmetics as described above are excellent in the speed of familiarity with the skin, excellent in the stability of the preparation, and transparent. The outstanding effect that a thru | or translucent external appearance can also be obtained can be show | played.
 なお、本発明において「透明乃至半透明」とは、精製水の透明度を100とし、全く光の透過がない場合を0としたときの透明度20~100の範囲のものをいう。牛乳様に白濁したエマルジョンは透明度15以下である。透明度の測定は常法によることができ、例えばデジタル測色色差計算機(スガ試験器(株)製)等を用いて行うことができる。 In the present invention, “transparent to translucent” refers to those having a transparency in the range of 20 to 100 when the transparency of the purified water is 100 and the case where no light is transmitted is 0. The milky milky emulsion has a transparency of 15 or less. The transparency can be measured by a conventional method, for example, using a digital colorimetric color difference calculator (manufactured by Suga Test Instruments Co., Ltd.).
 本発明の化粧料には、本発明の効果を損なわない範囲で、上記成分のほかに、通常化粧料に基剤として配合される保湿剤、界面活性剤(アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、親水性非イオン界面活性剤等)、油分(炭化水素油、合成エステル油、シリコーン油、液体油脂、固体油脂、ロウ類等)、高級脂肪酸、高級アルコール、粉末成分、水溶性高分子(天然、半合成、合成)、増粘剤、紫外線吸収剤、金属イオン封鎖剤、低級アルコール、糖類(単糖、オリゴ糖、多糖)、有機アミン、pH調整剤、ビタミン類、酸化防止剤、酸化防止助剤、その他の配合可能成分等を、必要に応じて適宜配合することができる。ただしこれら例示に限定されるものでない。 In the cosmetic of the present invention, a moisturizer and surfactant (anionic surfactant, cationic surfactant) usually incorporated as a base in cosmetics, in addition to the above components, within the range not impairing the effects of the present invention , Amphoteric surfactants, hydrophilic nonionic surfactants, etc.), oils (hydrocarbon oils, synthetic ester oils, silicone oils, liquid fats, solid fats, waxes, etc.), higher fatty acids, higher alcohols, powder components, water-soluble Polymers (natural, semi-synthetic, synthetic), thickeners, UV absorbers, sequestering agents, lower alcohols, saccharides (monosaccharides, oligosaccharides, polysaccharides), organic amines, pH adjusters, vitamins, oxidation An inhibitor, an antioxidant assistant, other components that can be blended, and the like can be blended as necessary. However, it is not limited to these examples.
 保湿剤としては、例えばグリセリン、ジグリセリン、トリグリセリン、テトラグリセリン等のポリグリセリン、エチレングリコール、1,3-ブチレングリコール、1,4-ブチレングリコール、プロピレングリコール、ジプロピレングリコール、ポリエチレングリコール、1,3-プロパンジオール、グルコース、マルトース、マルチトール、ショ糖、フラクトース、キシリトール、ソルビトール、マルトトリオース、スレイトール、エリスリトール、デンプン分解糖還元アルコール、ポリグリセリン誘導体、ポリオキシアルキレンアルキルグルコシド等が挙げられる。これらのうち、特にグリセリン、ジグリセリン、1,3-ブチレングリコール、1,4-ブチレングリコール、ジプロピレングリコール、ポリエチレングリコール、キシリトール、エリスリトール、ソルビトールが好ましい。配合量においては、保湿剤の種類によって若干の差はあるが、0.01~35.0質量%が好ましい。 Examples of the humectant include polyglycerin such as glycerin, diglycerin, triglycerin, tetraglycerin, ethylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, propylene glycol, dipropylene glycol, polyethylene glycol, 1, Examples include 3-propanediol, glucose, maltose, maltitol, sucrose, fructose, xylitol, sorbitol, maltotriose, threitol, erythritol, amylolytic sugar-reducing alcohol, polyglycerin derivative, polyoxyalkylene alkyl glucoside and the like. Of these, glycerin, diglycerin, 1,3-butylene glycol, 1,4-butylene glycol, dipropylene glycol, polyethylene glycol, xylitol, erythritol, and sorbitol are particularly preferable. The blending amount varies slightly depending on the type of humectant, but is preferably 0.01 to 35.0% by mass.
 アニオン界面活性剤としては、例えば、脂肪酸セッケン(例えば、ラウリン酸ナトリウム、パルミチン酸ナトリウム等);高級アルキル硫酸エステル塩(例えば、ラウリル硫酸ナトリウム、ラウリル硫酸カリウム等);アルキルエーテル硫酸エステル塩(例えば、POEラウリル硫酸トリエタノールアミン、POEラウリル硫酸ナトリウム等);N-アシルサルコシン酸(例えば、ラウロイルサルコシンナトリウム等);高級脂肪酸アミドスルホン酸塩(例えば、N-ミリストイル-N-メチルタウリンナトリウム、ヤシ油脂肪酸メチルタウリッドナトリウム、ラウリルメチルタウリッドナトリウム等);リン酸エステル塩(POEオレイルエーテルリン酸ナトリウム、POEステアリルエーテルリン酸等);スルホコハク酸塩(例えば、ジ-2-エチルヘキシルスルホコハク酸ナトリウム、モノラウロイルモノエタノールアミドポリオキシエチレンスルホコハク酸ナトリウム、ラウリルポリプロピレングリコールスルホコハク酸ナトリウム等);アルキルベンゼンスルホン酸塩(例えば、リニアドデシルベンゼンスルホン酸ナトリウム、リニアドデシルベンゼンスルホン酸トリエタノールアミン、リニアドデシルベンゼンスルホン酸等);高級脂肪酸エステル硫酸エステル塩(例えば、硬化ヤシ油脂肪酸グリセリン硫酸ナトリウム等);N-アシルグルタミン酸塩(例えば、N-ラウロイルグルタミン酸モノナトリウム、N-ステアロイルグルタミン酸ジナトリウム、N-ミリストイル-L-グルタミン酸モノナトリウム等);硫酸化油(例えば、ロート油等);POEアルキルエーテルカルボン酸;POEアルキルアリルエーテルカルボン酸塩;α-オレフィンスルホン酸塩;高級脂肪酸エステルスルホン酸塩;二級アルコール硫酸エステル塩;高級脂肪酸アルキロールアミド硫酸エステル塩;ラウロイルモノエタノールアミドコハク酸ナトリウム;N-パルミトイルアスパラギン酸ジトリエタノールアミン;カゼインナトリウム等が挙げられる。 Anionic surfactants include, for example, fatty acid soaps (eg, sodium laurate, sodium palmitate, etc.); higher alkyl sulfates (eg, sodium lauryl sulfate, potassium lauryl sulfate, etc.); alkyl ether sulfates (eg, POE lauryl sulfate triethanolamine, POE sodium lauryl sulfate, etc.); N-acyl sarcosine acid (eg, lauroyl sarcosine sodium, etc.); higher fatty acid amide sulfonates (eg, N-myristoyl-N-methyl taurine sodium, coconut oil fatty acid) Methyl tauride sodium, lauryl methyl tauride sodium, etc.); Phosphate ester salts (POE oleyl ether sodium phosphate, POE stearyl ether phosphate, etc.); Sulfosuccinate (eg, -2-sodium ethylhexylsulfosuccinate, sodium monolauroyl monoethanolamide polyoxyethylene sodium sulfosuccinate, sodium lauryl polypropylene glycol sulfosuccinate, etc .; alkyl benzene sulfonates (eg sodium linear dodecyl benzene sulfonate, triethanol linear dodecyl benzene sulfonate) Amines, linear dodecyl benzene sulfonic acid, etc.); higher fatty acid ester sulfates (eg, hydrogenated coconut oil fatty acid sodium glyceryl sulfate); N-acyl glutamate (eg, monosodium N-lauroyl glutamate, disodium N-stearoyl glutamate) N-myristoyl-L-monosodium glutamate, etc.); sulfated oil (eg funnel oil); POE alkyl Ether carboxylic acid; POE alkyl allyl ether carboxylate; α-olefin sulfonate; higher fatty acid ester sulfonate; secondary alcohol sulfate ester; higher fatty acid alkylolamide sulfate salt; sodium lauroyl monoethanolamide succinate; N-palmitoyl aspartate ditriethanolamine; sodium caseinate and the like.
 カチオン界面活性剤としては、例えば、アルキルトリメチルアンモニウム塩(例えば、塩化ステアリルトリメチルアンモニウム、塩化ラウリルトリメチルアンモニウム等);アルキルピリジニウム塩(例えば、塩化セチルピリジニウム等);塩化ジステアリルジメチルアンモニウムジアルキルジメチルアンモニウム塩;塩化ポリ(N,N’-ジメチル-3,5-メチレンピペリジニウム);アルキル四級アンモニウム塩;アルキルジメチルベンジルアンモニウム塩;アルキルイソキノリニウム塩;ジアルキルモリホニウム塩;POEアルキルアミン;アルキルアミン塩;ポリアミン脂肪酸誘導体;アミルアルコール脂肪酸誘導体;塩化ベンザルコニウム;塩化ベンゼトニウム等が挙げられる。 Examples of the cationic surfactant include alkyltrimethylammonium salts (eg, stearyltrimethylammonium chloride, lauryltrimethylammonium chloride, etc.); alkylpyridinium salts (eg, cetylpyridinium chloride, etc.); distearyldimethylammonium dialkyldimethylammonium chloride; Poly (N, N'-dimethyl-3,5-methylenepiperidinium chloride); alkyl quaternary ammonium salt; alkyldimethylbenzylammonium salt; alkylisoquinolinium salt; dialkyl morpholinium salt; POE alkylamine; Examples include amine salts; polyamine fatty acid derivatives; amyl alcohol fatty acid derivatives; benzalkonium chloride; benzethonium chloride and the like.
 両性界面活性剤としては、例えば、イミダゾリン系両性界面活性剤(例えば、2-ウンデシル-N,N,N-(ヒドロキシエチルカルボキシメチル)-2-イミダゾリンナトリウム、2-ココイル-2-イミダゾリニウムヒドロキサイド-1-カルボキシエチロキシ2ナトリウム塩等);ベタイン系界面活性剤(例えば、2-ヘプタデシル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン、ラウリルジメチルアミノ酢酸ベタイン、アルキルベタイン、アミドベタイン、スルホベタイン等)等が挙げられる。 Examples of amphoteric surfactants include imidazoline-based amphoteric surfactants (eg, 2-undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide). Side-1-carboxyethyloxy disodium salt, etc.); betaine surfactants (for example, 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetic acid betaine, alkylbetaine, amide betaine) , Sulfobetaine, etc.).
 親水性非イオン界面活性剤としては、例えば、POEソルビタン脂肪酸エステル類(例えば、POEソルビタンモノオレエート、POEソルビタンモノステアレート、POEソルビタンテトラオレエート等);POEソルビット脂肪酸エステル類(例えば、POEソルビットモノラウレート、POEソルビットモノオレエート、POEソルビットペンタオレエート、POEソルビットモノステアレート等);POEグリセリン脂肪酸エステル類(例えば、POEグリセリンモノステアレート、POEグリセリンモノイソステアレート、POEグリセリントリイソステアレート等のPOEモノオレエート等);POE脂肪酸エステル類(例えば、POEジステアレート、POEモノジオレエート、ジステアリン酸エチレングリコール等);POEアルキルエーテル類(例えば、POEラウリルエーテル、POEオレイルエーテル、POEステアリルエーテル、POE-ベヘニルエーテル、POE-2-オクチルドデシルエーテル、POEコレスタノールエーテル等);プルロニック型類;POE・POPアルキルエーテル類(例えば、POE・POPセチルエーテル、POE・POPモノブチルエーテル、POE・POPグリセリンエーテル等);テトラPOE・テトラPOPエチレンジアミン縮合物類(例えば、テトロニック等);POEヒマシ油硬化ヒマシ油誘導体(例えば、POE硬化ヒマシ油、POE硬化ヒマシ油モノイソステアレート、POE硬化ヒマシ油トリイソステアレート、POE硬化ヒマシ油モノピログルタミン酸モノイソステアリン酸ジエステル、POE硬化ヒマシ油マレイン酸等);POEミツロウ誘導体(例えば、POEソルビットミツロウ等);アルカノールアミド(例えば、ヤシ油脂肪酸ジエタノールアミド、ラウリン酸モノエタノールアミド、脂肪酸イソプロパノールアミド等);POEプロピレングリコール脂肪酸エステル;POEアルキルアミン;POE脂肪酸アミド;ショ糖脂肪酸エステル;アルキルエトキシジメチルアミンオキシド;トリオレイルリン酸等が挙げられる。 Examples of hydrophilic nonionic surfactants include POE sorbitan fatty acid esters (eg, POE sorbitan monooleate, POE sorbitan monostearate, POE sorbitan tetraoleate); POE sorbite fatty acid esters (eg, POE sorbit) Monolaurate, POE sorbite monooleate, POE sorbite pentaoleate, POE sorbite monostearate, etc.); POE glycerin fatty acid esters (for example, POE glycerin monostearate, POE glycerin monoisostearate, POE glycerin triisostearate) POE monooleate such as a rate); POE fatty acid esters (eg, POE distearate, POE monodiolate, ethylene glycol distearate, etc.); P E alkyl ethers (for example, POE lauryl ether, POE oleyl ether, POE stearyl ether, POE-behenyl ether, POE-2-octyldodecyl ether, POE cholestanol ether, etc.); Pluronic type; POE / POP alkyl ethers ( For example, POE / POP cetyl ether, POE / POP monobutyl ether, POE / POP glycerin ether, etc.); Tetra POE / tetra POP ethylenediamine condensates (for example, Tetronic, etc.); POE castor oil hardened castor oil derivatives (for example, POE) Hydrogenated castor oil, POE hydrogenated castor oil monoisostearate, POE hydrogenated castor oil triisostearate, POE hydrogenated castor oil monopyroglutamic acid monoisostearic acid diester, POE cured Male oil maleic acid etc.); POE beeswax derivatives (eg POE sorbite beeswax etc.); alkanolamides (eg coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, fatty acid isopropanolamide etc.); POE propylene glycol fatty acid ester; POE alkyl Examples include amines; POE fatty acid amides; sucrose fatty acid esters; alkylethoxydimethylamine oxides; trioleyl phosphoric acid.
 炭化水素油としては、例えば、流動パラフィン、イソドデカン、イソヘキサデカン、スクワラン、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックス等が挙げられる。 Examples of the hydrocarbon oil include liquid paraffin, isododecane, isohexadecane, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, and the like.
 合成エステル油としては、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、ステアリン酸イソセチル、イソステアリン酸イソセチル、ジ-2-エチルヘキサン酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N-アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ-2-ヘプチルウンデカン酸グリセリン、トリ-2-エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ-2-エチルヘキサン酸ペンタエリスリトール、トリ-2-エチルヘキサン酸グリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン、トリイソステアリン酸トリメチロールプロパン、セチル2-エチルヘキサノエート、2-エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ-2-ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オレイル、アセトグリセライド、パルミチン酸2-ヘプチルウンデシル、アジピン酸ジイソブチル、N-ラウロイル-L-グルタミン酸-2-オクチルドデシルエステル、アジピン酸ジ-2-ヘプチルウンデシル、エチルラウレート、セバシン酸ジ-2-エチルヘキシル、ミリスチン酸2-ヘキシルデシル、パルミチン酸2-ヘキシルデシル、アジピン酸2-ヘキシルデシル、セバシン酸ジイソプロピル、コハク酸2-エチルヘキシル、クエン酸トリエチル等が挙げられる。 Synthetic ester oils include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate, myristyl lactate , Isocetyl stearate, isocetyl isostearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, di-2-heptyl Glycerin undecanoate, tri-2-ethylhexanoic acid trimethylolpropane, triisostearic acid trimethylolpropane, tetra-2-ethylhexyl Pentaerythritol phosphate, glycerol tri-2-ethylhexanoate, glycerol trioctanoate, glycerol triisopalmitate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, glyceryl trimyristate, Tri-2-heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleyl oleate, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, adipic acid Di-2-heptylundecyl, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-adipate 2- Kishirudeshiru, diisopropyl sebacate, 2-ethylhexyl succinate, and triethyl citrate.
 シリコーン油としては、例えば、鎖状ポリシロキサン(例えば、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等);環状ポリシロキサン(例えば、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等)、3次元網目構造を形成しているシリコーン樹脂、シリコーンゴム、各種変性ポリシロキサン(アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等)等が挙げられる。 Examples of the silicone oil include linear polysiloxanes (for example, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxanes (for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexyl). And silicone resins that form a three-dimensional network structure, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.) It is done.
 液体油脂としては、例えば、アボガド油、ツバキ油、マカデミアナッツ油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油等が挙げられる。 Examples of liquid fats include avocado oil, camellia oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, eno oil , Soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, snail oil, Japanese drill oil, jojoba oil, germ oil and the like.
 固体油脂としては、例えば、カカオ脂、ヤシ油、硬化ヤシ油、パーム油、パーム核油、モクロウ核油、硬化油、モクロウ、硬化ヒマシ油等が挙げられる。 Examples of the solid fat include cocoa butter, coconut oil, hardened coconut oil, palm oil, palm kernel oil, owl kernel oil, hardened oil, owl, and hardened castor oil.
 ロウ類としては、例えば、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、モンタンロウ、ヌカロウ、カポックロウ、サトウキビロウ、ジョジョバロウ、セラックロウ等が挙げられる。 Examples of waxes include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, montan wax, nukarou, kapok wax, sugar cane wax, jojoballow, shellac wax, and the like.
 高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、オレイン酸、ウンデシレン酸、トール酸、イソステアリン酸、リノール酸、リノレイン酸、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)等が挙げられる。 Examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, toluic acid, isostearic acid, linoleic acid, linolenic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid ( DHA) and the like.
 高級アルコールとしては、例えば、直鎖アルコール(例えば、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール等);分枝鎖アルコール(例えば、モノステアリルグリセリンエーテル(バチルアルコール)、2-デシルテトラデシノール、フィトステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等)等が挙げられる。 Examples of higher alcohols include linear alcohols (eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol); branched chain alcohols (eg, monostearyl glycerin ether (batyl alcohol) ), 2-decyltetradecinol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol and the like.
 粉末成分としては、例えば、無機粉末(例えば、タルク、カオリン、雲母、絹雲母(セリサイト)、白雲母、金雲母、合成雲母、紅雲母、黒雲母、パーミキュライト、炭酸マグネシウム、炭酸カルシウム、ケイ酸アルミニウム、ケイ酸バリウム、ケイ酸カルシウム、ケイ酸マグネシウム、ケイ酸ストロンチウム、タングステン酸金属塩、マグネシウム、シリカ、ゼオライト、硫酸バリウム、焼成硫酸カルシウム(焼セッコウ)、リン酸カルシウム、弗素アパタイト、ヒドロキシアパタイト、セラミックパウダー、金属石鹸(例えば、ミリスチン酸亜鉛、パルミチン酸カルシウム、ステアリン酸アルミニウム)、窒化ホウ素等);有機粉末(例えば、ポリアミド樹脂粉末(ナイロン粉末)、ポリエチレン粉末、ポリメタクリル酸メチル粉末、ポリスチレン粉末、スチレンとアクリル酸の共重合体樹脂粉末、ベンゾグアナミン樹脂粉末、ポリ四弗化エチレン粉末、セルロース粉末等);無機白色顔料(例えば、二酸化チタン、酸化亜鉛等);無機赤色系顔料(例えば、酸化鉄(ベンガラ)、チタン酸鉄等);無機褐色系顔料(例えば、γ-酸化鉄等);無機黄色系顔料(例えば、黄酸化鉄、黄土等);無機黒色系顔料(例えば、黒酸化鉄、低次酸化チタン等);無機紫色系顔料(例えば、マンゴバイオレット、コバルトバイオレット等);無機緑色系顔料(例えば、酸化クロム、水酸化クロム、チタン酸コバルト等);無機青色系顔料(例えば、群青、紺青等);パール顔料(例えば、酸化チタンコーテッドマイカ、酸化チタンコーテッドオキシ塩化ビスマス、酸化チタンコーテッドタルク、着色酸化チタンコーテッドマイカ、オキシ塩化ビスマス、魚鱗箔等);金属粉末顔料(例えば、アルミニウムパウダー、カッパーパウダー等);ジルコニウム、バリウム又はアルミニウムレーキ等の有機顔料(例えば、赤色201号、赤色202号、赤色204号、赤色205号、赤色220号、赤色226号、赤色228号、赤色405号、橙色203号、橙色204号、黄色205号、黄色401号、及び青色404号などの有機顔料、赤色3号、赤色104号、赤色106号、赤色227号、赤色230号、赤色401号、赤色505号、橙色205号、黄色4号、黄色5号、黄色202号、黄色203号、緑色3号及び青色1号等);天然色素(例えば、クロロフィル、β-カロチン等)等が挙げられる。 Examples of the powder component include inorganic powders (for example, talc, kaolin, mica, sericite (sericite), muscovite, phlogopite, synthetic mica, saucite, biotite, permiculite, magnesium carbonate, calcium carbonate, silicic acid. Aluminum, barium silicate, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, silica, zeolite, barium sulfate, calcined calcium sulfate (baked gypsum), calcium phosphate, fluorine apatite, hydroxyapatite, ceramic powder , Metal soap (eg, zinc myristate, calcium palmitate, aluminum stearate), boron nitride, etc.); organic powder (eg, polyamide resin powder (nylon powder), polyethylene powder, polymethyl methacrylate powder, Restyrene powder, copolymer resin powder of styrene and acrylic acid, benzoguanamine resin powder, polytetrafluoroethylene powder, cellulose powder, etc .; inorganic white pigment (eg, titanium dioxide, zinc oxide, etc.); inorganic red pigment (eg, , Iron oxide (Bengara), iron titanate, etc.); inorganic brown pigment (eg, γ-iron oxide, etc.); inorganic yellow pigment (eg, yellow iron oxide, loess); inorganic black pigment (eg, black) Iron oxide, low-order titanium oxide, etc.); inorganic purple pigments (eg, mango violet, cobalt violet, etc.); inorganic green pigments (eg, chromium oxide, chromium hydroxide, cobalt titanate, etc.); inorganic blue pigments (eg, For example, ultramarine blue, bitumen, etc.); pearl pigments (eg, titanium oxide coated mica, titanium oxide coated bismuth oxychloride, titanium oxide coated titanium) Lac, colored titanium oxide coated mica, bismuth oxychloride, fish scale foil, etc.); metal powder pigments (eg, aluminum powder, copper powder, etc.); organic pigments such as zirconium, barium, or aluminum lake (eg, red 201, red 202) No., Red 204, Red 205, Red 220, Red 226, Red 228, Red 405, Orange 203, Orange 204, Yellow 205, Yellow 401, and Blue 404 Red No. 3, Red No. 104, Red No. 106, Red No. 227, Red No. 230, Red No. 401, Red No. 505, Orange No. 205, Yellow No. 4, Yellow No. 5, Yellow No. 202, Yellow No. 203, Green No. 3 and Blue No. 1); natural pigments (for example, chlorophyll, β-carotene, etc.) and the like.
 水溶性高分子としては、アラビアガム、トラガントガム、ガラクタン、グアーガム、ローカストビーンガム、タマリントガム、キャロブガム、カラヤガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)、グリチルリチン酸等の植物系水溶性高分子;キサンタンガム、デキストラン、サクシノグリカン、ブルラン等の微生物系水溶性高分子;コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系水溶性高分子;カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系水溶性高分子;メチルセルロース、ニトロセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロース(CMC)、結晶セルロース、セルロース末等のセルロース系水溶性高分子;アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系水溶性高分子;ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニルピロリドン、カルボキシビニルポリマー(カーボポール)等のビニル系水溶性高分子;ポリエチレングリコール20,000、同4,000,000、同600,000等のポリオキシエチレン系水溶性高分子;ポリオキシエチレンポリオキシプロピレン共重合体等の共重合系水溶性高分子;ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系水溶性高分子のほか、ポリエチレンイミン、カチオンポリマー、ベントナイト、ケイ酸AlMg(ビーガム)、ラポナイト、ヘクトライト、無水ケイ酸、デキストリン、ペクチン酸ナトリウム、ジアルキルジメチルアンモニウム硫酸セルロースなどが例示される。 Examples of water-soluble polymers include gum arabic, gum tragacanth, galactan, guar gum, locust bean gum, tamarind gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), alge colloid (gypsum extract), starch (rice, corn, Potato, wheat), plant water-soluble polymers such as glycyrrhizic acid; microbial water-soluble polymers such as xanthan gum, dextran, succinoglycan, and bullulan; animal water-soluble polymers such as collagen, casein, albumin, and gelatin; Starch-based water-soluble polymers such as carboxymethyl starch and methylhydroxypropyl starch; methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethyl Cellulose water-soluble polymers such as cellulose cellulose, sodium cellulose sulfate, hydroxypropyl cellulose, carboxymethyl cellulose (CMC), crystalline cellulose and cellulose powder; water-soluble alginic polymers such as sodium alginate and propylene glycol alginate; polyvinyl alcohol, Vinyl water-soluble polymers such as polyvinyl methyl ether, polyvinyl pyrrolidone, carboxyvinyl polymer (Carbopol); Polyoxyethylene water-soluble polymers such as polyethylene glycol 20,000, 4,000,000, and 600,000 Copolymerized water-soluble polymers such as polyoxyethylene polyoxypropylene copolymer; acrylic water-soluble polymers such as sodium polyacrylate, polyethyl acrylate, and polyacrylamide Other molecules, polyethyleneimine, cationic polymer, bentonite, AlMg silicate (bee gum), laponite, hectorite, silicic acid anhydride, dextrin, sodium pectate, and dialkyl dimethyl ammonium cellulose sulfate is exemplified.
 紫外線吸収剤としては、例えば、安息香酸系紫外線吸収剤(例えば、パラアミノ安息香酸(以下、PABAと略す)、PABAモノグリセリンエステル、N,N-ジプロポキシPABAエチルエステル、N,N-ジエトキシPABAエチルエステル、N,N-ジメチルPABAエチルエステル、N,N-ジメチルPABAブチルエステル、N,N-ジメチルPABAエチルエステル等);アントラニル酸系紫外線吸収剤(例えば、ホモメンチル-N-アセチルアントラニレート等);サリチル酸系紫外線吸収剤(例えば、アミルサリシレート、メンチルサリシレート、ホモメンチルサリシレート、オクチルサリシレート、フェニルサリシレート、ベンジルサリシレート、p-イソプロパノールフェニルサリシレート等);桂皮酸系紫外線吸収剤(例えば、オクチルシンナメート、エチル-4-イソプロピルシンナメート、メチル-2,5-ジイソプロピルシンナメート、エチル-2,4-ジイソプロピルシンナメート、メチル-2,4-ジイソプロピルシンナメート、プロピル-p-メトキシシンナメート、イソプロピル-p-メトキシシンナメート、イソアミル-p-メトキシシンナメート、オクチル-p-メトキシシンナメート(2-エチルヘキシル-p-メトキシシンナメート)、2-エトキシエチル-p-メトキシシンナメート、シクロヘキシル-p-メトキシシンナメート、エチル-α-シアノ-β-フェニルシンナメート、2-エチルヘキシル-α-シアノ-β-フェニルシンナメート、グリセリルモノ-2-エチルヘキサノイル-ジパラメトキシシンナメート等);ベンゾフェノン系紫外線吸収剤(例えば、2,4-ジヒドロキシベンゾフェノン、2,2’-ジヒドロキシ-4-メトキシベンゾフェノン、2,2’-ジヒドロキシ-4,4’-ジメトキシベンゾフェノン、2,2’,4,4’-テトラヒドロキシベンゾフェノン、2-ヒドロキシ-4-メトキシベンゾフェノン、2-ヒドロキシ-4-メトキシ-4’-メチルベンゾフェノン、2-ヒドロキシ-4-メトキシベンゾフェノン-5-スルホン酸塩、4-フェニルベンゾフェノン、2-エチルヘキシル-4’-フェニル-ベンゾフェノン-2-カルボキシレート、2-ヒドロキシ-4-n-オクトキシベンゾフェノン、4-ヒドロキシ-3-カルボキシベンゾフェノン等);3-(4’-メチルベンジリデン)-d,L-カンファー、3-ベンジリデン-d,l-カンファー;2-フェニル-5-メチルベンゾキサゾール;2,2’-ヒドロキシ-5-メチルフェニルベンゾトリアゾール;2-(2’-ヒドロキシ-5’-t-オクチルフェニル)ベンゾトリアゾール;2-(2’-ヒドロキシ-5’-メチルフェニルベンゾトリアゾール;ジベンザラジン;ジアニソイルメタン;4-メトキシ-4’-t-ブチルジベンゾイルメタン;5-(3,3-ジメチル-2-ノルボルニリデン)-3-ペンタン-2-オン等が挙げられる。 Examples of the ultraviolet absorber include benzoic acid-based ultraviolet absorbers (for example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester. N, N-dimethyl PABA ethyl ester, N, N-dimethyl PABA butyl ester, N, N-dimethyl PABA ethyl ester, etc.); anthranilic acid ultraviolet absorbers (eg, homomenthyl-N-acetylanthranylate, etc.); Salicylic acid UV absorbers (eg, amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate); Agents (eg, octyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-2,4-diisopropyl cinnamate, propyl-p- Methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, octyl-p-methoxycinnamate (2-ethylhexyl-p-methoxycinnamate), 2-ethoxyethyl-p-methoxycinnamate, Cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate, glyceryl mono-2-ethylhexanoyl-diparamethoxycinnamate, etc.) ; Nzophenone ultraviolet absorbers (for example, 2,4-dihydroxybenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2 ', 4,4 '-Tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone, 2 -Ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone, etc.); 3- (4'-methylbenzylidene) -d, L-Camphor, 3-Benz Den-d, l-camphor; 2-phenyl-5-methylbenzoxazole; 2,2'-hydroxy-5-methylphenylbenzotriazole; 2- (2'-hydroxy-5'-t-octylphenyl) benzo 2- (2′-hydroxy-5′-methylphenylbenzotriazole; dibenzalazine; dianisoylmethane; 4-methoxy-4′-tert-butyldibenzoylmethane; 5- (3,3-dimethyl-2-norbornylidene ) -3-pentan-2-one and the like.
 金属イオン封鎖剤としては、例えば、1-ヒドロキシエタン-1,1-ジフォスホン酸、1-ヒドロキシエタン-1,1-ジフォスホン酸四ナトリウム塩、エデト酸二ナトリウム、エデト酸三ナトリウム、エデト酸四ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、エデト酸、エチレンジアミンヒドロキシエチル三酢酸3ナトリウム等が挙げられる。 Examples of the sequestering agent include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, disodium edetate, trisodium edetate, and tetrasodium edetate. , Sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, edetic acid, trisodium ethylenediaminehydroxyethyl triacetate and the like.
 低級アルコールとしては、例えば、エタノール、プロパノール、イソプロパノール、イソブチルアルコール、t-ブチルアルコール等が挙げられる。 Examples of lower alcohols include ethanol, propanol, isopropanol, isobutyl alcohol, t-butyl alcohol and the like.
 単糖としては、例えば、三炭糖(例えば、D-グリセリルアルデヒド、ジヒドロキシアセトン等);四炭糖(例えば、D-エリトロース、D-エリトルロース、D-トレオース、エリスリトール等);五炭糖(例えば、L-アラビノース、D-キシロース、L-リキソース、D-アラビノース、D-リボース、D-リブロース、D-キシルロース、L-キシルロース等);六炭糖(例えば、D-グルコース、D-タロース、D-ブシコース、D-ガラクトース、D-フルクトース、L-ガラクトース、L-マンノース、D-タガトース等);七炭糖(例えば、アルドヘプトース、ヘプロース等);八炭糖(例えば、オクツロース等);デオキシ糖(例えば、2-デオキシ-D-リボース、6-デオキシ-L-ガラクトース、6-デオキシ-L-マンノース等);アミノ糖(例えば、D-グルコサミン、D-ガラクトサミン、シアル酸、アミノウロン酸、ムラミン酸等);ウロン酸(例えば、D-グルクロン酸、D-マンヌロン酸、L-グルロン酸、D-ガラクツロン酸、L-イズロン酸等)等が挙げられる。 Monosaccharides include, for example, tricarbon sugars (eg, D-glyceryl aldehyde, dihydroxyacetone, etc.); tetracarbon sugars (eg, D-erythrose, D-erythrulose, D-treose, erythritol, etc.); pentose sugars (eg, L-arabinose, D-xylose, L-lyxose, D-arabinose, D-ribose, D-ribulose, D-xylulose, L-xylulose, etc .; hexose (eg, D-glucose, D-talose, D) -Bucicose, D-galactose, D-fructose, L-galactose, L-mannose, D-tagatose, etc.); pentose sugar (eg, aldheptose, heproose, etc.); octose sugar (eg, octulose, etc.); For example, 2-deoxy-D-ribose, 6-deoxy-L-galactose, 6-deoxy- -Mannose, etc.]; amino sugars (eg, D-glucosamine, D-galactosamine, sialic acid, aminouronic acid, muramic acid, etc.); uronic acids (eg, D-glucuronic acid, D-mannuronic acid, L-guluronic acid, D -Galacturonic acid, L-iduronic acid, etc.).
 オリゴ糖としては、例えば、グンチアノース、ウンベリフェロース、ラクトース、プランテオース、イソリクノース類、α,α-トレハロース、ラフィノース、リクノース類、ウンビリシン、スタキオースベルバスコース類等が挙げられる。 Examples of oligosaccharides include guanthianose, umbelliferose, lactose, planteose, isoliquinoses, α, α-trehalose, raffinose, lycnose, umbilicin, stachyose verbus courses and the like.
 多糖としては、例えば、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ケラト硫酸、サクシノグルカン、カロニン酸等が挙げられる。 Examples of the polysaccharide include chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, keratan sulfate, chondroitin, mucoitin sulfate, keratosulfuric acid, succinoglucan, and caronic acid.
 アミノ酸としては、例えば、中性アミノ酸(例えば、スレオニン、システイン等);塩基性アミノ酸(例えば、ヒドロキシリジン等)等が挙げられる。また、アミノ酸誘導体として、例えば、アシルサルコシンナトリウム(ラウロイルサルコシンナトリウム)、アシルグルタミン酸塩、アシルβ-アラニンナトリウム、グルタチオン、ピロリドンカルボン酸等が挙げられる。 Examples of amino acids include neutral amino acids (eg, threonine, cysteine, etc.); basic amino acids (eg, hydroxylysine, etc.), and the like. Examples of amino acid derivatives include acyl sarcosine sodium (lauroyl sarcosine sodium), acyl glutamate, acyl β-alanine sodium, glutathione, pyrrolidone carboxylic acid and the like.
 有機アミンとしては、例えば、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、モルホリン、トリイソプロパノールアミン、2-アミノ-2-メチル-1,3-プロパンジオール、2-アミノ-2-メチル-1-プロパノール等が挙げられる。 Examples of organic amines include monoethanolamine, diethanolamine, triethanolamine, morpholine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, and 2-amino-2-methyl-1-propanol. Is mentioned.
 pH調製剤としては、例えば、乳酸-乳酸ナトリウム、クエン酸-クエン酸ナトリウム、コハク酸-コハク酸ナトリウム等の緩衝剤等が挙げられる。 Examples of the pH adjuster include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
 ビタミン類としては、例えば、ビタミンA、B1、B2、B6、C、Eおよびその誘導体、パントテン酸およびその誘導体、ビオチン等が挙げられる。 Examples of vitamins include vitamins A, B1, B2, B6, C, E and derivatives thereof, pantothenic acid and derivatives thereof, biotin and the like.
 酸化防止剤としては、例えば、トコフェロール類、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、没食子酸エステル類等が挙げられる。 Examples of the antioxidant include tocopherols, dibutylhydroxytoluene, butylhydroxyanisole, gallic acid esters and the like.
 酸化防止助剤としては、例えば、リン酸、クエン酸、アスコルビン酸、マレイン酸、マロン酸、コハク酸、フマル酸、ケファリン、ヘキサメタフォスフェイト、フィチン酸、エチレンジアミン四酢酸等が挙げられる。 Examples of the antioxidant assistant include phosphoric acid, citric acid, ascorbic acid, maleic acid, malonic acid, succinic acid, fumaric acid, kephalin, hexametaphosphate, phytic acid, ethylenediaminetetraacetic acid and the like.
 その他の配合可能成分としては、例えば、防腐剤(フェノキシエタノール、エチルパラベン等);消炎剤(例えば、グリチルリチン酸誘導体、グリチルレチン酸誘導体、サリチル酸誘導体、ヒノキチオール、酸化亜鉛、アラントイン等);美白剤(例えば、ユキノシタ抽出物、アルブチン等);各種抽出物(例えば、オウバク、オウレン、シコン、シャクヤク、センブリ、バーチ、セージ、ビワ、ニンジン、アロエ、ゼニアオイ、アイリス、ブドウ、ヨクイニン、ヘチマ、ユリ、サフラン、センキュウ、ショウキュウ、オトギリソウ、オノニス、ニンニク、トウガラシ、チンピ、トウキ、海藻等)、賦活剤(例えば、ローヤルゼリー、感光素等);血行促進剤(例えば、ノニル酸ワレニルアミド、ニコチン酸ベンジルエステル、ニコチン酸β-ブトキシエチルエステル、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、タンニン酸、α-ボルネオール、ニコチン酸トコフェロール、イノシトールヘキサニコチネート、シクランデレート、シンナリジン、トラゾリン、アセチルコリン、ベラパミル、セファランチン、γ-オリザノール等);抗脂漏剤(例えば、硫黄、チアントール等);抗炎症剤(例えば、トラネキサム酸、チオタウリン、ヒポタウリン等)等が挙げられる。 Other ingredients that can be blended include, for example, preservatives (phenoxyethanol, ethylparaben, etc.); anti-inflammatory agents (eg, glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin, etc.); whitening agents (for example, (Yukinoshita extract, arbutin, etc.); various extracts (for example, buckwheat, auren, shikon, peonies, assembly, birch, sage, loquat, carrot, aloe, mallow, iris, grape, yokuinin, loofah, lily, saffron, nematode, Ginger, hypericum, onion, garlic, red pepper, chimney, red pepper, seaweed, etc., activator (eg, royal jelly, photosensitizer, etc.); blood circulation promoter (eg, nonyl acid wallenyl amide, nicotinic acid benzyl ester, nicotinic acid) -Butoxyethyl ester, capsaicin, gingerone, cantalis tincture, ictamol, tannic acid, α-borneol, tocopherol nicotinate, inositol hexanicotinate, cyclandrate, cinnarizine, trazoline, acetylcholine, verapamil, cephalanthin, γ-oryzanol, etc. Antiseborrheic agents (for example, sulfur, thianthol, etc.); anti-inflammatory agents (for example, tranexamic acid, thiotaurine, hypotaurine, etc.) and the like.
 本発明の化粧料の剤型は、皮膚に適用可能であれば特に限定されるものでないが、化粧水、ローション、シート状基剤に含浸させる含浸液等が挙げられる。 The dosage form of the cosmetic of the present invention is not particularly limited as long as it can be applied to the skin, and examples thereof include skin lotion, lotion, and an impregnating liquid impregnated into a sheet-like base.
 以下に実施例を挙げて本発明をさらに具体的に説明するが、本発明はこれによってなんら限定されるものではない。配合量は特記しない限りすべて質量%である。 Hereinafter, the present invention will be described more specifically with reference to examples, but the present invention is not limited thereto. Unless otherwise specified, all the amounts are mass%.
 [透明性]
 デジタル測色色差計算機(スガ試験器(株)製)を用いて測定した。コントロールとして蒸留水の透明度を100として、20~98未満の範囲のものを半透明、98~99.5未満の範囲のものを透明、99.5~100の範囲のものを極めて透明と判定した。
[transparency]
Measurement was performed using a digital colorimetric color difference calculator (manufactured by Suga Test Instruments Co., Ltd.). As a control, the transparency of distilled water was set to 100, and the range of 20 to less than 98 was determined to be translucent, the range of 98 to less than 99.5 was transparent, and the range of 99.5 to 100 was determined to be extremely transparent. .
 [製剤安定性]
 0℃、室温、37℃、50℃での温度試験(1ヵ月間)を行い、次の基準に従って評価した。
(評価基準)
◎:各試験温度で分離、透明度の変化等異常は全く認められなかった
○:50℃、1ヶ月でわずかに分離、透明度の変化等異常が認められたが、実用上問題ない程度であった
△:37℃、1ヶ月で分離、透明度の変化等異常が認められた
×:室温、0℃、1ヶ月で分離、透明度の変化等異常が認められた
[Formulation stability]
A temperature test (one month) was performed at 0 ° C., room temperature, 37 ° C., and 50 ° C., and evaluation was performed according to the following criteria.
(Evaluation criteria)
A: No abnormality such as separation and change in transparency was observed at each test temperature. O: Abnormality such as slight separation and change in transparency was observed at 50 ° C. for one month, but there was no practical problem. Δ: Abnormalities such as separation and change in transparency were observed at 37 ° C for 1 month ×: Abnormalities such as separation and change in transparency were observed at room temperature, 0 ° C for 1 month
 [肌へのなじみの早さ]
 専門パネル(10名)により、実使用試験を実施し、肌へのなじみの早さについて官能評価を行った。下記採点基準による点数判定を行った。ここで、点数判定は、試料1(=(a)成分、(b)成分を配合しない試料)をコントロールの試料として、評価の基準とした。なお、各パネルによる点数の総和をパネル人数で割った平均値を算出し、下記評価基準に従い、評価結果とした。
(採点基準)
+3:コントロールの試料に比べて、肌へのなじみが非常に早い
+2:コントロールの試料に比べて、肌へのなじみが早い
+1:コントロールの試料に比べて、肌へのなじみがやや早い
 0:どちらともいえない
-1:コントロールの試料に比べて、肌へのなじみがやや遅い
-2:コントロールの試料に比べて、肌へのなじみが遅い
-3:コントロールの試料に比べて、肌へのなじみが非常に遅い
(評価基準)
◎:パネル10名の平均値が、+2.0点以上
○:パネル10名の平均値が、0.5以上2.0点未満
△:パネル10名の平均値が、-1.5点以上0.5点未満
×:パネル10名の平均値が、-1.5点未満
[Speed of familiarity with skin]
An actual use test was carried out by a specialized panel (10 persons), and sensory evaluation was performed on the speed of familiarity with the skin. The score was determined according to the following scoring criteria. Here, the score was determined by using the sample 1 (= (a) component, sample not containing the (b) component) as a control sample as a reference for evaluation. In addition, the average value which divided the sum total of the score by each panel by the panel number of persons was calculated, and it was set as the evaluation result according to the following evaluation criteria.
(Scoring criteria)
+3: Very familiar to skin compared to control sample +2: Faster to skin compared to control sample +1: Slightly familiar to skin compared to control sample 0: -1: Slightly familiar to the skin compared to the control sample -2: Slowly adapted to the skin compared to the control sample -3: Slightly adapted to the skin compared to the control sample Familiarity is very slow (evaluation criteria)
◎: The average value of 10 panelists is +2.0 or more ○: The average value of 10 panelists is 0.5 or more and less than 2.0 points △: The average value of 10 panel members is −1.5 points or more Less than 0.5 points x: The average value of 10 panelists is less than -1.5 points
 (実施例1)
 下記表1、2に示す試料1~20を調製した。各試料は(1)~(11)に該当する成分を混合し、これを別途(12)と(13)を混合したものに添加して調製した。
Example 1
Samples 1 to 20 shown in Tables 1 and 2 below were prepared. Each sample was prepared by mixing the components corresponding to (1) to (11) and separately adding this to the mixture of (12) and (13).
 得られた試料を用いて、上記評価方法に従い、透明性、製剤安定性、肌へのなじみの早さについて評価した。結果を表1、2に示す。なお、上述したように、肌へのなじみの早さについての評価は、試料1を基準にして行ったことから、表1中の試料1の「肌へのなじみの早さ」の評価を「-」として表した。 Using the obtained samples, according to the above evaluation methods, the transparency, the stability of the preparation, and the speed of familiarity with the skin were evaluated. The results are shown in Tables 1 and 2. As described above, since the evaluation of the speed of familiarity with the skin was performed with reference to the sample 1, the evaluation of “the speed of familiarity with the skin” of the sample 1 in Table 1 is “ -".
 表1、2中、「(a)成分(*1)」(=(a)-8)は上記式(I)で示すシリコーン系界面活性剤(式中、R1がメチル基、R2がメチル基、k=8を示す)を用いた。「(a)成分(*2)」(=(a)-17)は上記式(I)で示すシリコーン系界面活性剤(式中、R1がメチル基、R2がメチル基、k=17を示す)を用いた。「(b)成分(*3)」は上記式(II)で示す非イオン界面活性剤(式中、R3が2-デシルテトラデシル基、m=13、n=24を示す)を用いた。 In Tables 1 and 2, “(a) component (* 1) ” (= (a) -8) is a silicone surfactant represented by the above formula (I) (wherein R 1 is a methyl group, R 2 is Methyl group, k = 8 is used). “(A) component (* 2) ” (= (a) -17) is a silicone surfactant represented by the above formula (I) (wherein R 1 is a methyl group, R 2 is a methyl group, k = 17) Was used). As the “(b) component (* 3) ”, a nonionic surfactant represented by the above formula (II) (wherein R 3 represents a 2-decyltetradecyl group, m = 13, n = 24) was used. .
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008
 表1、2の結果から明らかなように、本発明構成要件を満足する試料7~20は半透明性~透明性、製剤安定性、肌へのなじみの早さのすべてにおいて優れた効果が得られた。一方、本発明構成要件を満足しない試料1~6は、本発明効果をすべて併せもつことはできなかった。例えば試料1では(a)成分、(b)成分ともに含まず、製剤安定性、肌へのなじみの早さも十分でなかった。試料2では(b)成分を含むが(a)成分を含まず、肌へのなじみの早さが十分でなかった。試料3では(a)成分を含むが(b)成分を含まず、透明乃至半透明な外観が得られず、製剤安定性にも劣るものであった。試料4では(b)成分に代えて他の非イオン界面活性剤を用いたところ、透明乃至半透明な外観が得られず、製剤安定性も十分でなかった。試料5、6では(a)成分に代えて他のシリコーン系界面活性剤を用いたところ、肌へのなじみの早さが得られなかった。 As is clear from the results in Tables 1 and 2, Samples 7 to 20 that satisfy the constituent requirements of the present invention have excellent effects in all of translucency to transparency, formulation stability, and speed of familiarity with the skin. It was. On the other hand, Samples 1 to 6 that do not satisfy the constituent requirements of the present invention could not have all the effects of the present invention. For example, sample 1 did not contain both component (a) and component (b), and the formulation stability and the speed of familiarity with the skin were not sufficient. Sample 2 contained the component (b) but did not contain the component (a), and the speed of familiarity with the skin was not sufficient. In Sample 3, the component (a) was included but the component (b) was not included, a transparent or translucent appearance was not obtained, and the formulation stability was poor. In sample 4, when other nonionic surfactant was used instead of the component (b), a transparent or translucent appearance was not obtained, and the preparation stability was not sufficient. In samples 5 and 6, when other silicone surfactant was used instead of component (a), the speed of familiarity with the skin was not obtained.
 以下、さらに本発明化粧料の処方例を示す。以下において(a)成分、(b)成分は実施例1で用いたものと同様のものを示す。 Hereafter, the formulation example of this invention cosmetics is shown. In the following, the components (a) and (b) are the same as those used in Example 1.
 [処方例1:化粧水]
  (配 合 成 分)              (質量%)
(1)グリセリン                  2.0
(2)1,3-ブチレングリコール          4.0
(3)エタノール                  1.0
(4)(a)成分                  0.1
(5)(b)成分                  0.2
(6)マリンコラーゲン               0.01
(7)フェノキシエタノール             0.3
(8)香料                     0.3
(9)エデト酸三ナトリウム             0.03
(10)精製水                   残余
〈製法〉
 (1)~(8)を混合し、これを別途(9)と(10)を混合したものに添加して、標題の化粧水を調製する。
[Prescription Example 1: Lotion]
(Mixed component) (mass%)
(1) Glycerin 2.0
(2) 1,3-butylene glycol 4.0
(3) Ethanol 1.0
(4) (a) component 0.1
(5) (b) component 0.2
(6) Marine collagen 0.01
(7) Phenoxyethanol 0.3
(8) Fragrance 0.3
(9) Edetate trisodium 0.03
(10) Purified water residue <Production method>
(1) to (8) are mixed and added separately to the mixture of (9) and (10) to prepare the title lotion.
 [処方例2:化粧水]
  (配 合 成 分)              (質量%)
(1)グリセリン                  5.0
(2)1,3-ブチレングリコール          4.0
(3)(a)成分                  0.2
(4)(b)成分                  0.3
(5)L-アスコルビン酸2-グルコシド       0.01
(6)フェノキシエタノール             0.3
(7)香料                     0.1
(8)エデト酸二ナトリウム             0.02
(9)精製水                    残余
〈製法〉
 (1)~(7)を混合し、これを別途(8)と(9)を混合したものに添加して、標題の化粧水を調製する。
[Prescription Example 2: Lotion]
(Mixed component) (mass%)
(1) Glycerin 5.0
(2) 1,3-butylene glycol 4.0
(3) (a) component 0.2
(4) (b) component 0.3
(5) L-ascorbic acid 2-glucoside 0.01
(6) Phenoxyethanol 0.3
(7) Fragrance 0.1
(8) Disodium edetate 0.02
(9) Purified water residue <Production method>
(1) to (7) are mixed and added separately to the mixture of (8) and (9) to prepare the title lotion.
 [処方例3:化粧水]
  (配 合 成 分)              (質量%)
(1)グリセリン                  3.0
(2)ソルビトール                 4.0
(3)エタノール                  2.0
(4)(a)成分                  0.3
(5)(b)成分                  0.3
(6)フェノキシエタノール             0.4
(7)香料                     0.2
(8)トラネキサム酸                2.3
(9)エデト酸三ナトリウム             0.03
(10)精製水                   残余
〈製法〉
 (1)~(7)を混合し、これを別途(8)~(10)を混合したものに添加して、標題の化粧水を調製する。
[Prescription Example 3: Lotion]
(Mixed component) (mass%)
(1) Glycerol 3.0
(2) Sorbitol 4.0
(3) Ethanol 2.0
(4) (a) component 0.3
(5) (b) component 0.3
(6) Phenoxyethanol 0.4
(7) Fragrance 0.2
(8) Tranexamic acid 2.3
(9) Edetate trisodium 0.03
(10) Purified water residue <Production method>
(1) to (7) are mixed and added separately to the mixture of (8) to (10) to prepare the title lotion.
 [処方例4:美容液]
  (配 合 成 分)              (質量%)
(1)グリセリン                  3.0
(2)ソルビトール                 4.0
(3)エタノール                  2.0
(4)(a)成分                  0.3
(5)(b)成分                  0.3
(6)カルボキシビニルポリマー           0.1
(7)フェノキシエタノール             0.4
(8)香料                     0.2
(9)水酸化カリウム                0.05
(10)エデト酸三ナトリウム            0.03
(11)精製水                   残余
〈製法〉
 (1)~(8)を混合し、これを別途(9)~(11)を混合したものに添加して、標題の美容液を調製する。
[Prescription Example 4: Cosmetic liquid]
(Mixed component) (mass%)
(1) Glycerol 3.0
(2) Sorbitol 4.0
(3) Ethanol 2.0
(4) (a) component 0.3
(5) (b) component 0.3
(6) Carboxyvinyl polymer 0.1
(7) Phenoxyethanol 0.4
(8) Fragrance 0.2
(9) Potassium hydroxide 0.05
(10) Trisodium edetate 0.03
(11) Purified water residue <Production method>
(1) to (8) are mixed and added separately to the mixture of (9) to (11) to prepare the title cosmetic liquid.
 [処方例5:美容液]
  (配 合 成 分)              (質量%)
(1)ジプロピレングリコール            4.0
(2)1,3-ブチレングリコール          4.0
(3)エタノール                  1.0
(4)(a)成分                  0.3
(5)(b)成分                  0.5
(6)キサンタンガム                0.05
(7)フェノキシエタノール             0.3
(8)香料                     0.1
(9)エデト酸二ナトリウム             0.03
(10)精製水                   残余
〈製法〉
 (1)~(8)を混合し、これを別途(9)と(10)を混合したものに添加して、標題の美容液を調製する。
[Prescription Example 5: Cosmetic liquid]
(Mixed component) (mass%)
(1) Dipropylene glycol 4.0
(2) 1,3-butylene glycol 4.0
(3) Ethanol 1.0
(4) (a) component 0.3
(5) (b) component 0.5
(6) Xanthan gum 0.05
(7) Phenoxyethanol 0.3
(8) Fragrance 0.1
(9) Edetate disodium 0.03
(10) Purified water residue <Production method>
(1) to (8) are mixed and added separately to the mixture of (9) and (10) to prepare the title cosmetic liquid.
 [処方例6:化粧水]
  (配 合 成 分)              (質量%)
(1)グリセリン                  3.0
(2)1,3-ブチレングリコール          2.0
(3)エタノール                  1.0
(4)(a)成分                  0.5
(5)(b)成分                  0.2
(6)ポリオキシエチレン硬化ヒマシ油        0.2
(7)フェノキシエタノール             0.3
(8)トラネキサム酸メチルアミド塩酸塩       1.0
(9)エデト酸三ナトリウム             0.03
(10)精製水                   残余
〈製法〉
 (1)~(7)を混合し、これを別途(8)~(10)を混合したものに添加して、標題の化粧水を調製する。
[Formulation Example 6: lotion]
(Mixed component) (mass%)
(1) Glycerol 3.0
(2) 1,3-butylene glycol 2.0
(3) Ethanol 1.0
(4) (a) component 0.5
(5) (b) component 0.2
(6) Polyoxyethylene hydrogenated castor oil 0.2
(7) Phenoxyethanol 0.3
(8) Tranexamic acid methylamide hydrochloride 1.0
(9) Edetate trisodium 0.03
(10) Purified water residue <Production method>
(1) to (7) are mixed, and this is added separately to the mixture of (8) to (10) to prepare the title lotion.
 本発明により、肌へのなじみの早さ、製剤安定性に優れる透明乃至半透明な化粧料が提供される。 According to the present invention, a transparent or translucent cosmetic material that is excellent in the speed of familiarity with the skin and the stability of the preparation is provided.

Claims (4)

  1.  (a)下記式(I)で示されるシリコーン系界面活性剤と、(b)下記式(II)で示される高級飽和分岐鎖アルコールのポリオキシプロピレン、ポリオキシエチレン付加物からなる非イオン界面活性剤を含有する、透明乃至半透明な化粧料。
    Figure JPOXMLDOC01-appb-I000001
    〔式(I)中、R1は炭素原子数1~6のアルキル基を示し;R2は水素原子または炭素原子数1~6のアルキル基を示し;kはエチレンオキシド基の平均付加モル数で3~30の数を示す。〕
    Figure JPOXMLDOC01-appb-I000002
    〔式(II)中、R3は炭素原子数20~30の脂肪族飽和分岐鎖アルキル基を示し;mはプロピレンオキシド基の平均付加モル数で11~15の数を示し(但し、高級飽和分岐アルコール母核と合せた分子量が930以上のポリオキシプロピレン付加物を示す。);nはエチレンオキシド基の平均付加モル数で15~30の数を示す。〕
    (A) a nonionic surfactant comprising a silicone-based surfactant represented by the following formula (I) and (b) a polyoxypropylene or polyoxyethylene adduct of a higher saturated branched chain alcohol represented by the following formula (II) A transparent or translucent cosmetic containing an agent.
    Figure JPOXMLDOC01-appb-I000001
    [In the formula (I), R 1 represents an alkyl group having 1 to 6 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; k represents an average number of moles of added ethylene oxide groups; Numbers from 3 to 30 are shown. ]
    Figure JPOXMLDOC01-appb-I000002
    [In the formula (II), R 3 represents an aliphatic saturated branched alkyl group having 20 to 30 carbon atoms; m represents an average added mole number of propylene oxide group of 11 to 15 (provided that higher saturation) And a polyoxypropylene adduct having a molecular weight of 930 or more in combination with the branched alcohol mother nucleus.); N represents an average number of moles of ethylene oxide groups added and 15 to 30. ]
  2.  (a)成分の配合量が0.01~3.0質量%である、請求項1記載の化粧料。 The cosmetic according to claim 1, wherein the amount of component (a) is 0.01 to 3.0% by mass.
  3.  (b)成分の配合量が0.02~5.0質量%である、請求項1記載の化粧料。 The cosmetic according to claim 1, wherein the amount of component (b) is 0.02 to 5.0 mass%.
  4.  (a)成分と(b)成分の配合比が(a)成分/(b)成分=1/400~90/1(質量比)である、請求項1記載の化粧料。 2. The cosmetic according to claim 1, wherein the mixing ratio of the component (a) and the component (b) is (a) component / (b) component = 1/400 to 90/1 (mass ratio).
PCT/JP2010/067061 2009-11-30 2010-09-30 Cosmetic WO2011065123A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009272657A JP2013032294A (en) 2009-11-30 2009-11-30 Cosmetic
JP2009-272657 2009-11-30

Publications (1)

Publication Number Publication Date
WO2011065123A1 true WO2011065123A1 (en) 2011-06-03

Family

ID=44066227

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2010/067061 WO2011065123A1 (en) 2009-11-30 2010-09-30 Cosmetic

Country Status (3)

Country Link
JP (1) JP2013032294A (en)
TW (1) TW201200159A (en)
WO (1) WO2011065123A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013203732A (en) * 2012-03-29 2013-10-07 Shiseido Co Ltd Oil-in-water type emulsified skin cosmetic

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1557551A (en) * 1967-03-31 1969-02-14
JPH08119826A (en) * 1994-10-25 1996-05-14 Shiseido Co Ltd Cosmetic
JP2001288031A (en) * 2000-04-04 2001-10-16 Nippon Unicar Co Ltd Additive for hair-growing agent and hair-growing agent composition
JP2010059117A (en) * 2008-09-05 2010-03-18 Kao Corp Skin lotion

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1557551A (en) * 1967-03-31 1969-02-14
JPH08119826A (en) * 1994-10-25 1996-05-14 Shiseido Co Ltd Cosmetic
JP2001288031A (en) * 2000-04-04 2001-10-16 Nippon Unicar Co Ltd Additive for hair-growing agent and hair-growing agent composition
JP2010059117A (en) * 2008-09-05 2010-03-18 Kao Corp Skin lotion

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KEN'ICHI HONO: "Newly developed silicones for cosmetics", FRAGRANCE JOURNAL, vol. 25, no. 10, 1997, pages 99 - 102 *
YASUO NOMURA: "Newly developed silicones for cosmetics", FRAGRANCE JOURNAL, vol. 29, no. 1, 2001, pages 87 - 92 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013203732A (en) * 2012-03-29 2013-10-07 Shiseido Co Ltd Oil-in-water type emulsified skin cosmetic

Also Published As

Publication number Publication date
TW201200159A (en) 2012-01-01
JP2013032294A (en) 2013-02-14

Similar Documents

Publication Publication Date Title
JP5241011B2 (en) Oil-in-water emulsified sunscreen cosmetics
JP5461010B2 (en) Topical skin preparation
JP5553411B2 (en) Skin preparation
JP5263940B2 (en) Topical skin preparation
JP2016037497A (en) Solid powder cosmetic
JP5305574B2 (en) Topical skin preparation
JP2009242321A (en) Skin care preparation
WO2001045665A1 (en) Skin preparations for external use
JP3673924B2 (en) Topical skin preparation
WO2017073758A1 (en) Composition
WO2017159566A1 (en) Oil-in-water type composition
JP2010024161A (en) Fine emulsion composition and method for producing the same
JP5022618B2 (en) Hydroxyalkylated hyaluronic acid
JP2006249049A (en) Skin care composition
JP2010275206A (en) Cosmetic
JP2005272454A (en) External preparation for skin
JP2004018375A (en) Oily cosmetics
JP4349883B2 (en) Skin external composition
JP5154904B2 (en) Topical skin preparation
WO2011065123A1 (en) Cosmetic
JP2010047506A (en) Sol-gel reversible composition, thickening agent, and cosmetic material
WO2011102526A1 (en) Cosmetic preparation
JP2002047122A (en) Cosmetic
JP2006045133A (en) Oil-in-water type emulsion composition
JP4301499B2 (en) Skin external composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10832970

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10832970

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP